Oamic holds 5 PCT international patents, 13 Chinese patents, 3 US patents and 3 European patents.

Our goal is to acquire more than 10 patents per year.

Oamic’s innovative technology of the biosynthesis of vanillin via ferulic acid has achieved global leadership. In addition, we have pioneered a number of innovative technology, including the manufacture of natural chiral lactones and many other special products.

We invested $2.5 million to introduce a glycerine derivative technology from Inventure Renewables Inc. of the United States. The use of glycerol intermediates, combined with our downstream process, will greatly improve the production process of a series of pharmaceutical products, reducing more than 95% of the production pollution. This gives our products a considerable cost advantage.

We believe that evolutionary thinking can bring us more innovation!